Profit with us in the 2009 bear market
   

Biotechnology Stock

Industrial Biotechnology Corp.

Cardinal Health, Inc.

Cardinal Health, Inc., an Ohio corporation formed in 1979, is a holding company that owns operating subsidiaries conducting business as Cardinal Health. The Company is a leading provider of products and services supporting the healthcare industry, and helping healthcare providers and manufacturers improve the productivity and safety of healthcare. As used in this report, the terms the ... more

Antares Pharma, Inc

Antares Pharma, Inc. (“Antares” or the “Company”) is a specialized pharma product development and pipeline company with patented drug delivery platforms including Advanced Transdermal Delivery (ATD™) gels, fast-melt oral (Easy Tec™) tablets, disposable mini-needle injection systems (Vibex™), and reusable needle-free injection systems (VISION ® AND ... more

Geron Corp

      Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. We are advancing telomerase targeted therapies, including an anticancer drug and a cancer vaccine, through multiple clinical trials. We are also the world leader in the development ... more

Becton, Dickinson And Company

      Becton, Dickinson and Company (also known as “BD”) was incorporated under the laws of the State of New Jersey in November 1906, as successor to a New York business started in 1897. BD’s executive offices are located at 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, and its telephone number is (201) 847-6800. All references in this Form ... more

Sepracor, Inc

LUNESTA brand eszopiclone is a non-benzodiazepine used for the treatment of insomnia. Symptoms of insomnia include difficulty falling asleep, awakening frequently during the night, waking up too early, an inability to fall back to sleep, or awakening feeling unrefreshed. LUNESTA is approved for long- or short-term treatment of sleep onset and sleep maintenance insomnia. LUNESTA is classified ... more

Insmed, Inc

We are a biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Our development activities involve drugs that modulate Insulin-like Growth Factor-1 (IGF-1) activity in the human body. In the past, we were focused on development and commercialization of ... more

Cytrx Corp

CytRx Corporation engages in the research and development of human therapeutic products. Their products are dedicated to the treatment of amyotrophic lateral sclerosis (ALS), neurodegenerative diseases, cancer, type 2 diabetes, obesity and stickle cell disease as well as other disorders. more

Acadia Pharmaceuticals, Inc

We are a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. We currently have five programs in clinical development and several additional programs in preclinical development and discovery stages. In our most advanced proprietary program, we are entering Phase III development ... more

Osi Pharm, Inc

     We are a mid-cap biotechnology company committed to building a scientifically strong and financially successful top tier biopharmaceutical organization that discovers, develops and commercializes innovative molecular targeted therapies addressing major unmet medical needs in oncology, diabetes and obesity. more

Stem Cell Innovation

Stem Cell Innovations, Inc. engages in the development and production of stem cells for the United States market. more

Corn Products International, Inc.

     Corn Products International, Inc. was incorporated as a Delaware corporation in 1997 and its common stock is traded on the New York Stock Exchange. Corn Products International, Inc., together with its subsidiaries, manufactures and sells a number of ingredients to a wide variety of food and industrial customers. more

Theravance, Inc

We have never commercialized any of our product candidates. We are uncertain whether any of our compounds or product candidates will prove effective and safe in humans or meet applicable regulatory standards. In addition, our approach to applying our expertise in multivalency to drug discovery is unproven and may not result in the creation of successful medicines. The risk of failure for ... more

Affymetrix, Inc

We are engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets and are recognized as a market leader in creating breakthrough tools that are advancing our understanding of the molecular basis of life. The markets for our products currently include all aspects of molecular biology research in ... more

Biosite, Inc

Founded in 1988, Biosite ®  Incorporated is a global medical diagnostic company utilizing a biotechnology approach to create products for the diagnosis of critical diseases and conditions. Our primary business goal is to leverage our research and development advances and our installed base of existing customers to deliver first-in-class blood tests that provide diagnostic ... more

previous  1  2  3  4  5  6  7  8  9  next     total items: 404
   
   
   
   
   

Add to Google
Add to My Yahoo!
Feedburner
rss
rss Full-text
 
 
Home > Directory > Biotechnology Stock